Pfizer Races to Salvage Obesity Drugmaker Deal After Novo’s Bid – Bloomberg.com

Pfizer Races to Salvage Obesity Drugmaker Deal After Novo’s Bid  Bloomberg.comNovo Nordisk bids $9bn for obesity drug maker Metsera in challenge to Pfizer  The GuardianNovo Nordisk Tries to Snatch a Weight-Loss Biotech From Pfizer. There Are Political Risks.  Barron’sNovo Nordisk’s new CEO is chasing the deals its former leaders wouldn’t  Endpoints NewsNovo tops Pfizer with $6.5B bid for Metsera  BioPharma Dive